Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: If PTSC owned half the license - the the 3.5% should come only from TPL...

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

optymystic

Rank: President [?]

Points: 18922 [?]

Votes: 159 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: If PTSC owned half the license - the the 3.5% should come only from TPL...

in response to

Re: If PTSC owned half the license - the the 3.5% should come only from TPL...

mikesmark

posted on Jan 07, 2013 03:01PM

< i interpretate that brown gets his part beeing 3,5% of the gross (overall) revenue from tpls share, so ptsc share is not touched! no?>

That is correct. The reason that the court determined that gross MMP revs meant total MMP revenue (including PTSC's share), is because TPL was the sole licensing agent. Brown is due 3.5% on the total license revenue as long as TPL remained the sole licensor on the docs. The Js settlement was one of the exceptions since PTSC is also listed as licensing agent.

But PTSC was not a party to the Brown litigation, hence we are not responsible for payment of what is due to Mr Brown.